# A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials

> **NCT01337479** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 1097 (actual)

## Conditions studied

- Hepatitis B

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01337479
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 1097 (ACTUAL)
- **Last updated:** 2011-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01337479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01337479, "A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01337479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*